Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fouillard

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|June 24, 1989
Recombinant human granulocyte-macrophage colony-stimulating factor plus the beam regimen instead of autologous bone marrow transplantationL Fouillard, N C Gorin, J P Laporte, et al.
Bone Marrow Transplantation|December 1, 1999
In vivo expansion of reinfused autologous peripheral blood stem cells after a myeloablative regimen, as an alternative to ex vivo expansion pretransplantation: an intriguing observation in apatient autografted twiceL Fouillard, J Laporte, L Douay, et al.
Lupus|July 21, 1999
Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral bloodL Fouillard, N C Gorin, J P Laporte, et al.
Lancet (London, England)|November 25, 1989
GM-CSF and ganciclovir for cytomegalovirus infection after autologous bone-marrow transplantationL Fouillard, N C Gorin, J P Laporte, et al.
Leukemia|July 8, 2005
Complete remission with bortezomib on plasmocytomas in an end-stage patient with refractory multiple myeloma who failed all other therapies including hematopoietic stem cell transplantation: possible enhancement of graft-vs-tumor effectE Paubelle, P Coppo, L Garderet, et al.
Bone Marrow Transplantation|November 7, 2002
Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registryL Fouillard, M Labopin, A Gratwohl, et al.
Bone Marrow Transplantation|June 1, 2000
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, N C Gorin, et al.
Lancet (London, England)|September 7, 1991
GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimenJ P Laporte, L Fouillard, L Douay, et al.
Leukemia|August 6, 2004
A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplantJ Ph Laporte, M Yeshurun, L Fouillard, et al.
Bone Marrow Transplantation|June 5, 1998
Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantationL Fouillard, E Deconinck, P Tiberghien, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|June 24, 1989
Recombinant human granulocyte-macrophage colony-stimulating factor plus the beam regimen instead of autologous bone marrow transplantationL Fouillard, N C Gorin, J P Laporte, et al.
Bone Marrow Transplantation|December 1, 1999
In vivo expansion of reinfused autologous peripheral blood stem cells after a myeloablative regimen, as an alternative to ex vivo expansion pretransplantation: an intriguing observation in apatient autografted twiceL Fouillard, J Laporte, L Douay, et al.
Lupus|July 21, 1999
Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral bloodL Fouillard, N C Gorin, J P Laporte, et al.
Lancet (London, England)|November 25, 1989
GM-CSF and ganciclovir for cytomegalovirus infection after autologous bone-marrow transplantationL Fouillard, N C Gorin, J P Laporte, et al.
Leukemia|July 8, 2005
Complete remission with bortezomib on plasmocytomas in an end-stage patient with refractory multiple myeloma who failed all other therapies including hematopoietic stem cell transplantation: possible enhancement of graft-vs-tumor effectE Paubelle, P Coppo, L Garderet, et al.
Bone Marrow Transplantation|November 7, 2002
Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registryL Fouillard, M Labopin, A Gratwohl, et al.
Bone Marrow Transplantation|June 1, 2000
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, N C Gorin, et al.
Lancet (London, England)|September 7, 1991
GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimenJ P Laporte, L Fouillard, L Douay, et al.
Leukemia|August 6, 2004
A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplantJ Ph Laporte, M Yeshurun, L Fouillard, et al.
Bone Marrow Transplantation|June 5, 1998
Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantationL Fouillard, E Deconinck, P Tiberghien, et al.
Pageof 6